Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

Photodynamic therapy of disseminated non-small cell lung carcinoma in a murine model.

Grossman CE, Pickup S, Durham A, Wileyto EP, Putt ME, Busch TM.

Lasers Surg Med. 2011 Sep;43(7):663-75. doi: 10.1002/lsm.21102.

2.

Fluence Rate Differences in Photodynamic Therapy Efficacy and Activation of Epidermal Growth Factor Receptor after Treatment of the Tumor-Involved Murine Thoracic Cavity.

Grossman CE, Carter SL, Czupryna J, Wang L, Putt ME, Busch TM.

Int J Mol Sci. 2016 Jan 14;17(1). pii: E101. doi: 10.3390/ijms17010101.

3.

Photodynamic therapy using methylene blue in lung adenocarcinoma xenograft and hamster cheek pouch induced squamous cell carcinoma.

Obstoy B, Salaun M, Bohn P, Veresezan L, Sesboué R, Thiberville L.

Photodiagnosis Photodyn Ther. 2016 Sep;15:109-14. doi: 10.1016/j.pdpdt.2016.03.003. Epub 2016 Mar 15.

4.

Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors.

Henderson BW, Gollnick SO, Snyder JW, Busch TM, Kousis PC, Cheney RT, Morgan J.

Cancer Res. 2004 Mar 15;64(6):2120-6.

5.

2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (HPPH) in a nude rat glioma model: implications for photodynamic therapy.

Lobel J, MacDonald IJ, Ciesielski MJ, Barone T, Potter WR, Pollina J, Plunkett RJ, Fenstermaker RA, Dougherty TJ.

Lasers Surg Med. 2001;29(5):397-405.

PMID:
11891727
6.

Photodynamic therapy with Pd-Bacteriopheophorbide (TOOKAD): successful in vivo treatment of human prostatic small cell carcinoma xenografts.

Koudinova NV, Pinthus JH, Brandis A, Brenner O, Bendel P, Ramon J, Eshhar Z, Scherz A, Salomon Y.

Int J Cancer. 2003 May 10;104(6):782-9.

7.

High-field magnetic resonance imaging of the response of human prostate cancer to Pc 4-based photodynamic therapy in an animal model.

Fei B, Wang H, Meyers JD, Feyes DK, Oleinick NL, Duerk JL.

Lasers Surg Med. 2007 Oct;39(9):723-30.

8.

Intraoperative photodynamic therapy of the chest cavity in malignant pleural mesothelioma bearing rats.

Krueger T, Pan Y, Tran N, Altermatt HJ, Opitz I, Ris HB.

Lasers Surg Med. 2005 Oct;37(4):271-7.

PMID:
16245295
9.

Fluence plays a critical role on the subsequent distribution of chemotherapy and tumor growth delay in murine mesothelioma xenografts pre-treated by photodynamic therapy.

Wang Y, Wang X, Le Bitoux MA, Wagnieres G, Vandenbergh H, Gonzalez M, Ris HB, Perentes JY, Krueger T.

Lasers Surg Med. 2015 Apr;47(4):323-30. doi: 10.1002/lsm.22329. Epub 2015 Jan 12.

PMID:
25639847
10.

Photodynamic therapy (PDT) using HPPH for the treatment of precancerous lesions associated with Barrett's esophagus.

Nava HR, Allamaneni SS, Dougherty TJ, Cooper MT, Tan W, Wilding G, Henderson BW.

Lasers Surg Med. 2011 Sep;43(7):705-12. doi: 10.1002/lsm.21112.

11.

Photodynamic therapy with 3-(1'-hexyloxyethyl) pyropheophorbide a for cancer of the oral cavity.

Rigual N, Shafirstein G, Cooper MT, Baumann H, Bellnier DA, Sunar U, Tracy EC, Rohrbach DJ, Wilding G, Tan W, Sullivan M, Merzianu M, Henderson BW.

Clin Cancer Res. 2013 Dec 1;19(23):6605-13. doi: 10.1158/1078-0432.CCR-13-1735. Epub 2013 Oct 2.

12.

Effect of tumor host microenvironment on photodynamic therapy in a rat prostate tumor model.

Chen B, Pogue BW, Zhou X, O'Hara JA, Solban N, Demidenko E, Hoopes PJ, Hasan T.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):720-7.

14.

A Phase I Study of Light Dose for Photodynamic Therapy Using 2-[1-Hexyloxyethyl]-2 Devinyl Pyropheophorbide-a for the Treatment of Non-Small Cell Carcinoma In Situ or Non-Small Cell Microinvasive Bronchogenic Carcinoma: A Dose Ranging Study.

Dhillon SS, Demmy TL, Yendamuri S, Loewen G, Nwogu C, Cooper M, Henderson BW.

J Thorac Oncol. 2016 Feb;11(2):234-41. doi: 10.1016/j.jtho.2015.10.020. Epub 2015 Dec 22.

15.

Tumor vascular response to photodynamic therapy and the antivascular agent 5,6-dimethylxanthenone-4-acetic acid: implications for combination therapy.

Seshadri M, Spernyak JA, Mazurchuk R, Camacho SH, Oseroff AR, Cheney RT, Bellnier DA.

Clin Cancer Res. 2005 Jun 1;11(11):4241-50.

16.

Photodynamic therapy for malignant mesothelioma: preclinical studies for optimization of treatment protocols.

Schouwink H, Ruevekamp M, Oppelaar H, van Veen R, Baas P, Stewart FA.

Photochem Photobiol. 2001 Apr;73(4):410-7.

PMID:
11332037
17.

Photodynamic therapy for sarcoma pulmonary metastases: a preclinical toxicity study.

Anderson TM, Dougherty TJ, Tan D, Sumlin A, Schlossin JM, Kanter PM.

Anticancer Res. 2003 Sep-Oct;23(5A):3713-8.

PMID:
14666668
18.
19.

Experimental photodynamic therapy for malignant pleural mesothelioma with pegylated mTHPC.

Krueger T, Altermatt HJ, Mettler D, Scholl B, Magnusson L, Ris HB.

Lasers Surg Med. 2003;32(1):61-8.

PMID:
12516073
20.

Photodynamic therapy of human lung cancer xenografts in mice.

Nwogu C, Pera P, Bshara W, Attwood K, Pandey R.

J Surg Res. 2016 Jan;200(1):8-12. doi: 10.1016/j.jss.2015.07.024. Epub 2015 Jul 17.

PMID:
26494011

Supplemental Content

Support Center